Relay Therapeutics
NASDAQ: RLAYCambridge, US · Delaware corporation · 3 known investors
Improving patients' lives by accelerating development and commercialization of medicines that matter.
Biotech
Founders & leadership
SK
Sanjiv K. PatelExecutive
DA
Donald A. BergstromExecutive
TC
Thomas CatinazzoNamed on SEC filing
PR
Peter RahmerNamed on SEC filing
SK
Sekar KathiresanNamed on SEC filing
DS
Douglas S. IngramNamed on SEC filing
MM
Mark MurckoNamed on SEC filing
LS
Laura ShawverNamed on SEC filing
BA
Brian AdamsNamed on SEC filing
LH
Linda HillNamed on SEC filing
JR
Jami RubinNamed on SEC filing
Board
AB
Alexis BorisyBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2024
▶$30MraisedJan 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$30MraisedJan 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas CatinazzoExecutive Officer
- Peter RahmerExecutive Officer
- Sekar KathiresanDirector
- Douglas S. IngramDirector
- Sanjiv K. PatelExecutive Officer, Director
- Mark MurckoDirector
- Laura ShawverDirector
- Brian AdamsExecutive Officer
- Linda HillDirector
- Jami RubinDirector
- Donald A. BergstromExecutive Officer
- Alexis BorisyDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Relay Therapeutics do?
- Improving patients' lives by accelerating development and commercialization of medicines that matter.
- Who are Relay Therapeutics's investors?
- Relay Therapeutics's investors include Commonweal Ventures, Foresite Capital, Curie.Bio.
- How much funding has Relay Therapeutics raised?
- Relay Therapeutics has disclosed $30M raised across 1 round.
- Where is Relay Therapeutics headquartered?
- Relay Therapeutics is headquartered in Cambridge, US.